Inagene Diagnostics Inc. provides genetic testing services to help individuals understand their response to medications and optimize their health based on their genetic makeup. The services include tests for medication response, general health, pain, mental health, cardiovascular health, nutrition, and fitness.

Inagene Diagnostics Inc.

23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.

Linda Avey

Paul Cusenza

Anne Wojcicki

23andMe Holding Co.

Foundation Medicine, Inc. develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.

Alexis Borisy

Foundation Medicine, Inc.

Inagene Diagnostics Inc | 1,107 followers on LinkedIn. Health shouldn’t wait. Make it personal.

Inagene Diagnostics aims to be a trusted ally working to shorten the journey to optimal health.

Wallace Watson

Entrepreneur, Healthcare Executive & Member of the Board

Nancy White

Pharmacist Leader | Pharmacy Innovation & Disruption | Obsessed with Advancement

Ashwin Juneja, MBA, PharmD

Head of Marketing

Suzanne Laughton

Inagene Diagnostics Inc

Not everyone reacts to prescription drugs in the same way. In fact, most people don't. Earlier this year, the manufacturers and distributors of the popular blood thinner Plavix were ordered to pay Hawaii $916 million for failing to disclose key information about the medication’s efficacy and safety after it was found to produce a diminished response in 30% of patients—many of whom are non-Caucasian. This was of particular interest to the state of Hawaii, as it could disproportionately affect Indigenous Polynesian communities. The reality is that over 99.9% of the population has genetic variations that impact how pharmaceutical medications are processed by the body. Pharmacogenetic (PGx) testing aims to reduce harm and adverse drug events by equipping patients with personalized health data to help them choose medications best suited to their genetic makeup. Making this testing standard practice could lead to a safer healthcare system—not only with fewer cases of diminished response and adverse events, but also fewer lawsuits. This is the future we envision at Inagene. Read more here: https://lnkd.in/gTkmpVrz

Have you ever suspected that you may have a sensitivity or intolerance to gluten? You may carry one of the five common gene variants linked to gluten sensitivity. Inagene’s Nutrition & Fitness test, created in partnership with Nutrigenomix® , provide personalized nutrition insights, including key food intolerances like gluten. Within the same test, you’ll also receive information on: - Nutrient Metabolism - Cardiometabolic Health - Weight Management and Body Composition - Eating Habits - Exercise Physiology, Fitness and Injury Risk With insights provided in your results, you can make lifestyle and dietary adjustments to feel your best more often. Ready to get started? Order your Nutrition & Fitness Test Kit at the link in the comments.

About 80% of people treated with antidepressants for anxiety, stress or OCD experience side effects. Our Pain & Mental Health test will provide you with life-long insights to help you and your health care provider limit trial and error, avoid side effects, and improve your outcomes sooner. The report includes personalized recommendations for more than 85 medications commonly used in the treatment of pain and mental health conditions. Learn more about this test on our website. Find the link in the comments!

Meet our Mass-spectrometer! This is the machine we use to analyse DNA that helps us understand how your genes impact your medication response. Your results are guaranteed to be 99.9% accurate. This machine strikes large molecules with laser energy into minimal ion fragments to determine the molecular weight of proteins, peptides, and other macromolecules (1). Mass spectrometers have been used for DNA analysis since 1988 (2). You may have heard of a mass-spectrometer before. In 1999, at the start of the 86th Tour de France it was announced that the National Laboratory for the Detection of Doping will give the results of its research concerning the detection of natural and synthetic corticoids (3). They were now able to employ the technique of mass spectrometry on a rider’s urine sample and better analyse its chemical make-up to identify who was doping (3). Lance Armstrong was one of the people caught by the new test. Mass spectrometry has played a decisive role in doping analysis and doping control in human sport for almost 40 years. The standard of qualitative and quantitative determinations in body fluids has always attracted maximum attention from scientists. With its unique sensitivity and selectivity properties, mass spectrometry provides state-of-the-art technology in analytical chemistry (4). Sources: 1) https://lnkd.in/gP_xGCJH 2) https://lnkd.in/gSCaF_yY 3) https://lnkd.in/gDbyqtyW 4) https://lnkd.in/gxmb6RfT

Curious about what’s included with an Inagene Test Kit? Once you place your order online, we’ll send you everything you need to get your personalized health insights. In your Test Kit, you’ll find: - A Cheek Swab Kit, with a cheek swab and a sealed Lab-Loc bag to place your swab in. - A step-by-step guide to help you collect your sample. - Your unique 14-digit code to register your Test Kit on the Inagene Portal. This code ensures the protection and privacy of your personal information. - A prepaid return label to ship your sample to our Health Canada-licensed lab. When your results are ready, you’ll be able to download your personalized insights report through the Inagene Portal. We understand how frustrating it can be to navigate your health journey, which is why we aim to empower you with the tools you need to thrive. We’re with you every step of the way. Ready to get started? Shop our Test Kits now: https://lnkd.in/gi86Qf5k

Thousands of people die each year from adverse drug events caused by medications taken as prescribed to them. Our goal is to help change this. According to research, over 99.9% of people have genetic variants that affect how medications work. This includes: - Antidepressants and other psychiatric medications - Cancer medications - Statins - Blood pressure medications - Pain management medications And many more. With pharmacogenetics, we can help identify which medications are right for you, and which ones may cause side effects that may cause harm or lead to the discontinuation of treatment. When you’re equipped with the right information, it’s possible to improve your outcomes sooner, without having to rely on trial and error. Understanding your health shouldn’t be complicated, which is why we make it easy. With the help of pharmacogenetics, we can put a stop to preventable deaths caused by adverse drug reactions.

Pharmacogenetics (PGx) is the future. According to this eye-opening article, 275,000 American lives are lost each year to adverse drug events (ADEs)—the majority of which involve medications prescribed and taken correctly. That’s 20% more lives lost annually than from unintentional injuries, like car accidents (read more at the link in the comments). On top of the unnecessary cost of lives, the article points out that drug-related morbidity and mortality resulting from nonoptimized medication therapy was $528.4 billion—a staggering 16% of total US health care expenditures. Consider, for instance, the 8% of patients with PGx variations affecting the metabolism of common antidepressants like Citalopram and Escitalopram. These patients are 34.3% more likely to end their lives because the medications metabolize too quickly to offer therapeutic benefits. Or think of the countless cancer patients who die each year not from cancer, but from the medications meant to treat it. Fortunately, these reactions and the high costs straining healthcare systems can be reduced. Over 99.9% of people have genetic variations that impact how they metabolize medications. PGx testing can reveal which medications are most effective for each patient based on their unique genetics. Legislation is now pushing to make PGx testing the standard of care, with the potential to save thousands of lives and billions of dollars every year. In the meantime, Inagene is committed to supporting Canadians through comprehensive PGx testing, because this isn’t just helpful information—it’s potentially lifesaving. Read more here: https://lnkd.in/gyJUFidi

Research shows that 99.9% of people have genetic variants that affect their response to medications. On top of that, many people don't know that their genetics play a role in this and that tests are available to help them find answers. Dr. Ben Pinder joined Lindsay Dixon on the Friendly Pharmacy 5 podcast to discuss pharmacogenomics and the importance of taking this test before an emergency occurs. Lindsay also talks about her own experience with the test, "I actually was fortunate enough to do the test myself, and I actually have this genetic variant for clopidogrel. I'm one of those 25%. So if something happens to me, I will actually have this knowledge already. But having that knowledge for me was really life-changing." Visit the links in the comments to watch the full interview and to learn more about the new cardiovascular health test.

At Inagene, we understand your concerns about privacy, which is why we work hard to ensure that your personal genetic information is protected at every step. Here’s how: → Your sample is completely anonymous. When you send us your swab, we label it so it cannot be traced back to you, using it solely to provide personalized health insights. → Your personal data and DNA are never shared or sold. We fully comply with Canadian Data Protection regulations. → Your personal information is never shared with our lab. Lab technicians have no access to your identity. In fact, we sequence only 0.0000066% of your DNA, which includes no identifying information. → DNA samples are securely destroyed once testing is complete. No lingering genetic material can be accessed or misused in the future. → Test results are securely encrypted. We store your data safely, protecting it from breaches or unauthorized access. → We ensure transparency at every touchpoint. If you ever have questions about the security of your private information, we are here to help answer any questions you may have. For more information, visit the link in the comments.

Paul had never heard of PGx testing, so when a family-member recommended it, he was surprised by the comprehensiveness of the test and it's results. "The experience is quite easy and the thing that pleased me the most was when my doctor looked at it and said, 'wow, this is pretty impressive'. So, you know, I did something right for my own health and well-being." Take our quiz to see which Inagene test is right for you. Visit the link in the comments to take the quiz.

Metric
Company Name	Inagene Diagnostics Inc.	23	Foundation Medicine, Inc.
Symbol		ME
MSH ID	COM:INAGENE	COM:23ANDME	COM:FOUNDATIONMEDICINE
Market	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Medical Diagnostics	Medical - Diagnostics & Research	Biotechnology
Country	CA	US	US
Stage			Series B
Employee Count		560	1.84K
Website	inagene.com	23andme.com	foundationmedicine.com
LinkedIn	inagene-diagnostics-inc	23andme	foundation-medicine
Founders

Metric
Market Cap		225.52M
Enterprise Value
Monthly Web Traffic	273	6.55M	40.74K
Web Traffic Growth	-0.68	-0.06	-0.28
Valuation
Raised Capital			13.50M

Metric
Revenue		219.64M
Revenue (LTM)
Revenue (NTM)
Gross Profit		99.38M
EBITDA		-291.88M
Operating Income		-321.36M
Net Income		-666.70M
EPS		-1.40
Diluted EPS		-1.40
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.45
Operating Profit Margin		-2.17
EBITDA Margin		-1.33
Net Profit Margin		-2.10
Return on Equity		-0.87
Return on Assets		-0.86
Return on Capital Employed		-1.16

INAG

COM:INAGENE

Inagene Diagnostics Inc.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-0.93
P/B Ratio		0.50
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		13.37
EV Multiple		-3.85

Metric
Days Sales Outstanding		2.03
Days Payables Outstanding		21.21
Days Inventory Outstanding		48.94
Operating Cycle		97.37
Cash Conversion Cycle		62.09
Asset Turnover		0.56

Metric
Operating Cash Flow		-155.53M
Free Cash Flow		-165.19M
Cash Flow to Debt		-1.75
Operating Cash Flow/Sales		-0.65
Free Cash Flow Yield		-0.50

Metric
Cash & Equivalents		217.89M
Accounts Receivable		-1.43M
Inventory		12.46M
Goodwill
Debt to Capitalization		0.34
Debt to Assets		0.10
Current Ratio		2.93
Quick Ratio		1.87

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.49
R&D to Revenue		0.87
SG&A to Revenue		0.53